Cargando…

SK-216, a Novel Inhibitor of Plasminogen Activator Inhibitor-1, Suppresses Lung Metastasis of Human Osteosarcoma

Lung metastasis constitutes the leading cause of the death in patients with osteosarcoma. We have previously reported that plasminogen activator inhibitor-1 (PAI-1) regulates the invasion and lung metastasis of osteosarcoma cells in a mouse model and as well as in clinical samples. In the present st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuge, Minori, Osaki, Mitsuhiko, Sasaki, Ryo, Hirahata, Mio, Okada, Futoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877597/ https://www.ncbi.nlm.nih.gov/pubmed/29510576 http://dx.doi.org/10.3390/ijms19030736

Ejemplares similares

MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma
por: Sasaki, Ryo, et al.
Publicado: (2019)

PAI‐1, a target gene of miR‐143, regulates invasion and metastasis by upregulating MMP‐13 expression of human osteosarcoma
por: Hirahata, Mio, et al.
Publicado: (2016)

Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis.
por: Yoshino, H., et al.
Publicado: (1998)

MTA1, a metastasis-associated protein, in endothelial cells is an essential molecule for angiogenesis
por: Ishikawa, Mizuho, et al.
Publicado: (2022)

Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes
por: Sakamoto, Kazutaka, et al.
Publicado: (2011)

miRNA‐216 knockdown has effects to suppress osteosarcoma via stimulating PTEN
por: Jiang, Ping, et al.
Publicado: (2020)

The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients
por: Goto, Keisuke, et al.
Publicado: (2022)

Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction
por: Kanda, Yusuke, et al.
Publicado: (2017)

AMIGO2 contained in cancer cell-derived extracellular vesicles enhances the adhesion of liver endothelial cells to cancer cells
por: Izutsu, Runa, et al.
Publicado: (2022)

miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
por: Ji, Quanbo, et al.
Publicado: (2017)

AMIGO2 as a novel indicator of liver metastasis in patients with colorectal cancer
por: Tanio, Akimitsu, et al.
Publicado: (2021)

Korean Red Ginseng Suppresses Metastasis of Human Hepatoma SK-Hep1 Cells by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase Plasminogen Activator
por: Ho, Yu-Ling, et al.
Publicado: (2012)

Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical Aspects
por: Okada, Futoshi, et al.
Publicado: (2021)

Lysosome-associated membrane protein 2 (LAMP-2) expression induced by miR-194-5p downregulation contributes to sunitinib resistance in human renal cell carcinoma cells
por: Yumioka, Tetsuya, et al.
Publicado: (2018)

Inverse Correlation between mRNA Expression of Plasminogen Activator Inhibitor‐2 and Lymph Node Metastasis in Human Breast Cancer
por: Ishikawa, Noboru, et al.
Publicado: (1996)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

miR-216b-5p promotes late apoptosis/necroptosis in trastuzumab-resistant SK-BR-3 cells
por: DOLAPÇI, İştar Burcu, et al.
Publicado: (2023)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
Publicado: (2018)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
por: Andersen, Matilde Kanstrup, et al.
Publicado: (2023)

The circadian rhythm of bladder clock genes in the spontaneously hypersensitive rat
por: Kimura, Yusuke, et al.
Publicado: (2019)

Splice variants of lysosome-associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells
por: Nishikawa, Ryoma, et al.
Publicado: (2020)

Correction: The circadian rhythm of bladder clock genes in the spontaneously hypersensitive rat
por: Kimura, Yusuke, et al.
Publicado: (2019)

Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis
por: Suh, Yun-Suhk, et al.
Publicado: (2015)

Functional Stability of Plasminogen Activator Inhibitor-1
por: Yasar Yildiz, Songul, et al.
Publicado: (2014)

Activators and inhibitors of the plasminogen system in Alzheimer’s disease
por: Barker, Rachel, et al.
Publicado: (2012)

Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum‐based chemotherapy
por: Nakatsuru, Kousei, et al.
Publicado: (2023)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1
por: Nishioka, N, et al.
Publicado: (2011)

Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice()
por: Gamble, Joanne, et al.
Publicado: (2013)

Memorandum 216
por: Smith, G A
Publicado: (1985)

Plasminogen Activator Inhibitor-1 Is Involved in Streptozotocin-Induced Bone Loss in Female Mice
por: Tamura, Yukinori, et al.
Publicado: (2013)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Plasminogen activator inhibitor type 2 in breast cancer.
por: Duggan, C., et al.
Publicado: (1997)

Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?
por: Bruyère, Françoise, et al.
Publicado: (2010)

Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease
por: Nam, Da-eun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6h6redv9rsp86c8ja5d08e9ojm